Paola Bertolotti, MD, PhD, MEDSIR, Barcelona, Spain, emphasizes the importance of diversity in oncology research, highlighting the need for inclusive clinical trials that reflect the diverse realities of cancer risk and outcomes, including genetic differences, lifestyle, and environmental factors. Increasing gender diversity in clinical trials and supporting female scientists in leadership positions can lead to better and more inclusive healthcare solutions for all patients. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.